June 4, 2018 — The U.S. Food and Drug Administration said Medtronic initiated a Class 1 recall all 204,017 of its...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congesitive heart failure (CHF). The channel includes news on HFpEF and HFrEF.
News | Ventricular Assist Devices (VAD) | May 23, 2018
May 23, 2018 — Abbott has initiated a Class I recall of the HeartMate 3...
News | Cardiac Resynchronization Therapy Devices (CRT) | May 22, 2018
May 22, 2018 — Medtronic plc announced...
Image courtesy of Impulse Dynamics
News | Heart Failure | May 18, 2018
May 18, 2018 — In a new study, cardiac...
News | Heart Failure | May 16, 2018
May 16, 2018 — Israel-based V-Wave Ltd. recently closed a $70 million Series C financing for its proprietary,...
News | Heart Failure | May 14, 2018
May 14, 2018 — Ancora Heart Inc. announced the expansion of the company’s U.S....
A PET scan detects clumping proteins in rat hearts (top). The enlarged heart (right) is one with heart failure. Other PET scans showing blood flow in the rat hearts (bottom) show that the protein clumps aren't due to circulation problems. Image courtesy of Circulation Research, May 11, 2018.
News | Heart Failure | May 11, 2018
May 11, 2018 — A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to...
The CORolla device from Israel-based CorAssist is one example of new devices being manufactured and tested to treat heart failure. The efficacy of this and other new devices under development can now be assessed with the Minnesota Living With Heart Failure Questionnaire.
Technology | Heart Failure | May 07, 2018
May 7, 2018 — The U.S. Food and Drug Administration (FDA) has qualified the Minnesota Living with...
News | Hemodynamic Support Devices | April 12, 2018
April 12, 2018 – French medical technology company CorWave announced it has been awarded almost $3.5 million in...
News | Pharmaceuticals | April 06, 2018
April 6, 2018 — Pfizer Inc. announced that the Tafamidis Phase 3 Transthyretin Cardiomyopathy (ATTR-ACT) study met...
Image courtesy of The Ohio State University
News | Heart Failure | April 04, 2018
April 4, 2018 — The Ohio State University Wexner Medical Center will establish the nation’s first center dedicated...
News | Heart Failure | March 29, 2018
March 29, 2018 — Abbott announced the company has initiated the landmark GUIDE-HF...
News | Cath Lab | March 21, 2018
March 21, 2018 — Hundreds of hospitals across the United States will have access to tools and resources to help...
